Simon Fear
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Final results of the global and Asia cohorts of KAMILLA, a phase IIIB safety trial of trastuzumab emtansine in patients with HER2-positive advanced breast cancer.
Journal: ESMO open
Published: February 25, 2022
Effectiveness of Additional Risk Minimization Measures for Atezolizumab in the European Union.
Journal: Pharmaceutical medicine
Published: October 25, 2021
Phase II multicohort study of atezolizumab monotherapy in multiple advanced solid cancers.
Journal: ESMO open
Published: October 04, 2021
Safety and Efficacy of Atezolizumab in Understudied Populations with Pretreated Urinary Tract Carcinoma: Subgroup Analyses of the SAUL Study in Real-World Practice.
Journal: The Journal of urology
Published: April 09, 2021
Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma.
Journal: European urology focus
Published: August 29, 2020
Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 01, 2020
Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract.
Journal: European urology
Published: February 08, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026